Disease-specific survival of men with prostate cancer detected during the screening interval: Results of the European Randomized Study of Screening for Prostate Cancer-Rotterdam after 11 years of follow-up

European Urology

Volumn 60, Issue 2, 2011, Pages 330-336

  Zhu, Xiaoye ^a   Van Leeuwen, Pim J ^a   Bul, Meelan ^a   Otto, Suzie J ^a   De Koning, Harry J ^a   Bangma, Chris H ^a   Schröder, Fritz H ^a   Roobol, Monique J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Early detection of cancer; Mass screening; Prostate neoplasms; Prostate specific antigen; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; BIOPSY; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DIGITAL RECTAL EXAMINATION; EARLY DETECTION OF CANCER; EUROPE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 79959560114     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.05.013     Document Type: Article

References (27)

1. I. Andersson, K. Aspegren, and L. Janzon Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial BMJ 297 1988 943 948
2. P. Bordas, H. Jonsson, L. Nystrom, and P. Lenner Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden J Med Screen 16 2009 39 45
3. J. Frisell, A. von Rosen, M. Wiege, B. Nilsson, and S. Goldman Interval cancer and survival in a randomized breast cancer screening trial in Stockholm Breast Cancer Res Treat 24 1992 11 16 (Pubitemid 23012688)
4. L.H. Holmberg, L. Tabar, H.O. Adami, and R. Bergstrom Survival in breast cancer diagnosed between mammographic screening examinations Lancet 2 1986 27 30 (Pubitemid 16063767)
5. S. Shapiro, W. Venet, P. Strax, L. Venet, and R. Roeser Ten- to fourteen-year effect of screening on breast cancer mortality J Natl Cancer Inst 69 1982 349 355 (Pubitemid 12018584)
6. N. Malila, T. Oivanen, O. Malminiemi, and M. Hakama Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design BMJ 337 2008 a2261
7. R.A. Smith, V. Cokkinides, and O.W. Brawley Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues CA Cancer J Clin 58 2008 161 179 (Pubitemid 351830300)
8. M.J. Roobol, W.J. Kirkels, and F.H. Schroder Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands) BJU Int 92 Suppl 2 2003 48 54 (Pubitemid 38091140)
9. L.A. Eskew, R.L. Bare, and D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199 202 discussion 203
10. Follow up of the target population and ascertainment of interval cancers. In: Perry N, Broeders M, deWolf C, et al, editors. European guidelines for quality assurance in breast cancer screening and diagnosis, ed 4. Luxembourg: Office for Official Publications of the European Communities; 2006. p. 37.
11. D.F. Gleason, and G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 1974 58 64
12. F.H. Schroder, P. Hermanek, L. Denis, W.R. Fair, M.K. Gospodarowicz, and M. Pavone-Macaluso The TNM classification of prostate cancer Prostate Suppl 4 1992 129 138
13. H.J. De Koning, J. Blom, and J.W. Merkelbach Determining the cause of death in randomized screening trial(s) for prostate cancer BJU Int 92 Suppl 2 2003 71 78 (Pubitemid 38091145)
14. Zhu X, van Leeuwen PJ, Bul M, Bangma CH, Roobol MJ, Schroder FH. Identifying and characterizing "escapes" - men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam). Int J Cancer. In press. DOI:10.1002/ijc.25947.
15. M.J. Roobol, M. Kerkhof, and F.H. Schröder Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Eur Urol 56 2009 584 591
16. F.H. Schröder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
17. D.P. Ankerst, J. Groskopf, and J.R. Day Predicting prostate cancer risk through incorporation of prostate cancer gene 3 J Urol 180 2008 1303 1308 discussion 1308
18. F.K. Chun, A. de la Taille, and H. van Poppel Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram Eur Urol 56 2009 659 668
19. M.J. Roobol, E.W. Steyerberg, and R. Kranse A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer Eur Urol 57 2010 79 85
20. F.H. Jansen, R.H.N. van Schaik, and J. Kurstjens Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection Eur Urol 57 2010 921 927
21. G.L. Andriole, D.G. Bostwick, and O.W. Brawley Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192 1202
22. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224 (Pubitemid 36859473)
23. O. Gustafsson, U. Norming, and L.E. Almgard Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2,400 men J Urol 148 1992 1827 1831
24. P.C. Prorok, G.L. Andriole, and R.S. Bresalier Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Control Clin Trials 21 2000 273S 309S
25. R.L. Grubb 3rd, P.F. Pinsky, and R.T. Greenlee Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: update on findings from the initial four rounds of screening in a randomized trial BJU Int 102 2008 1524 1530
26. J. Hugosson, G. Aus, and S. Bergdahl Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden BJU Int 92 Suppl 2 2003 39 43 (Pubitemid 38091138)
27. J. Hugosson, G. Aus, H. Lilja, P. Lodding, and C.G. Pihl Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma Cancer 100 2004 1397 1405 (Pubitemid 38366842)